So sánh phương pháp

	Nghiên cứu Độ chính xác Chẩn đoán Điều chỉnh theo Rủi ro	Đánh giá Xét nghiệm Sàng lọc
Lĩnh vực	Dịch tễ học	Dịch tễ học
Họ	Process / pipeline	Process / pipeline
Năm ra đời	Conceptual roots 1980s–1990s; covariate-adjusted ROC formally introduced 2009	1968 (Wilson-Jungner principles); statistical framework developed 1970s–2000s
Người khởi xướng	Margaret Pepe and colleagues; covariate-adjusted ROC formalized by Janes & Pepe (2009)	Wilson & Jungner (WHO criteria, 1968); foundational work by Pepe, Altman, and others in statistical test evaluation
Loại	Observational clinical study design with covariate adjustment	Observational diagnostic / epidemiological evaluation design
Công trình gốc	Pepe, M. S. (2003). The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford University Press. ISBN: 978-0198509844	Wilson, J. M. G., & Jungner, G. (1968). Principles and Practice of Screening for Disease. World Health Organization. Public Health Papers No. 34.
Tên gọi khác	case-mix-adjusted diagnostic accuracy, stratified diagnostic accuracy study, covariate-adjusted diagnostic accuracy, risk-stratified DTA study	screening study, screening performance evaluation, screening accuracy assessment, STE
Liên quan	6	6
Tóm tắt	A risk-adjusted diagnostic accuracy study evaluates how well an index test identifies a target condition while explicitly accounting for patient-level risk factors that influence either disease prevalence or test performance. By adjusting for case-mix, it yields accuracy estimates — sensitivity, specificity, and AUC — that are not confounded by the composition of the study sample, enabling fairer comparisons across populations and clinical settings.	Screening test evaluation is a systematic epidemiological approach for assessing whether a test or program can accurately and cost-effectively identify individuals with a condition before symptoms appear. It quantifies diagnostic performance metrics — sensitivity, specificity, predictive values, and the ROC curve — and evaluates whether a screening program meets established public health criteria for adoption and harm-benefit balance.